Matters of legal in nature including licensing, intellectual property, and lawsuits.
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday,... Read more
Basel, 27 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumours... Read more
WASHINGTON, Aug. 24, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced that, effective April 1, 2022, Georgeann F. Couchara will succeed Angela S. Lalor as Senior Vice President, Human Resources. At that time, Ms. Lalor will move to a part time, advisory role until her retirement in the first quarter of 2023. Ms. Couchara, currently Vice President,... Read more
FIREFISH Part 2 study showed treatment with Evrysdi helped babies stay free of permanent ventilation, sit without support and improve across a range of motor milestones Evrysdi has proven efficacy in adults, children and babies two months and older with over 4,000 patients treated to date SMA is the leading genetic cause of death in... Read more
July 27, 2021 at 6:30 AM EDTPDF Version Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The... Read more
Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer; Karen E. Nelson joins the company as new CSO WALTHAM, Mass., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Alan Sachs, who has served... Read more
New VIP-HESI ion source boosts sensitivity in analytical flow 4D-Metabolomics, 4D-Lipidomics and small molecule quantitative screening workflows by more than 10x Introducing new METLIN-4D large 4D-Metabolomics CCS library for timsTOF platform Integration of machine integration for CCS-Predict Pro software for unknown metabolites New CCS-enabled 4D workflows in MetaboScape and TASQ 2022 software, including 4D-Lipidomics tools... Read more
Rakuten Medical and Shimadzu Corporation announce a joint development and commercialization agreement on a medical device to be used with the Illuminox™ platform Read more